Market Data
Market Cap₹478.41 Cr.
52W High₹471.85
Current Price₹315
52W Low₹225
Down from 52W High33.2 %
Face Value₹10
Performance
ROCE-579.54 %
ROE62.96 %
EPS (TTM)₹-18.28
EPS Prev Qtr₹-23.41
EPS Last Year₹-10.76
EBITDA Qtr₹-24.3 Cr.
Book Value₹-101
Financial Health
Debt/Equity-1.07
Debt/Profit-1.7
Total Assets₹277.91 Cr.
Promoter Holding51.43 %
Earning Power-24.39 %
Valuation
Industry P/E40.59
Price to Book-3.13
Price to Sales2.15
Key Metrics
Face Value
₹10
About Kaya Ltd
Healthcare · Healthcare
Kaya Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹10. Market cap ₹478.41 Cr.
Price Chart
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 59.87 | ₹1,25,119.97 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Manipal Health Enterprises Ltd | - | - | ₹98,508.6 Cr | - | - | - | - | - | - | 1.25 |
| Max Healthcare Institute Ltd | - | 65.64 | ₹95,762.32 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Aster DM Quality Care Ltd | - | 118.98 | ₹64,094.07 Cr | 0.41% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.01 | ₹61,831.07 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 68.38 | ₹38,058.8 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 44.88 | ₹36,850.34 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 47.16 | ₹32,792.46 Cr | 1.25% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 151 | ₹32,344.7 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.78 | ₹16,633.09 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 105.51 | ₹15,685.91 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 81.03 | ₹15,200.42 Cr | 0.14% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 66.95 | ₹14,863.1 Cr | 0.34% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.18 | ₹14,568.1 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹14,188.59 Cr | - | - | - | - | - | - | 0.35 |
| Rainbow Childrens Medicare Ltd | - | 48.68 | ₹13,896.34 Cr | 0.26% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Park Medi World Ltd | - | 38.3 | ₹11,942.89 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.09 | ₹11,664.5 Cr | 0.89% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.81 | ₹10,653.42 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 452.55 | ₹10,472.8 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 52.79 | 53.85 | 60.04 | 55.8 |
| ↳ QoQ Growth | - | +2.0% | +11.5% | -7.1% |
| Expenses | 59.01 | 68.11 | 83.05 | 80.1 |
| Operating Profit | -6.21 | -14.26 | -23.01 | -24.3 |
| OPM % | -11.76% | -26.48% | -38.32% | -43.55% |
| Other Income | 0.61 | 4.42 | 1.66 | 2 |
| Interest | 8.49 | 8.92 | 9.02 | 9.2 |
| Depreciation | 9.92 | 10.91 | 11.56 | 11.62 |
| EBITDA | 3.71 | -3.35 | -11.45 | -12.68 |
| EBITDA Margin % | 7.03% | -6.22% | -19.07% | -22.72% |
| Profit Before Tax | -14.09 | -18.76 | -35.56 | -27.77 |
| Tax % | 0% | 0% | 0% | 0% |
| Net Profit | -14.09 | -18.76 | -35.56 | -27.77 |
| ↳ QoQ Growth | - | -33.1% | -89.6% | +21.9% |
| EPS | -10.76 | -13.18 | -23.41 | -18.28 |
Profit & Loss
| Mar 2026 | TTM | |
|---|---|---|
| Sales | 222.48 | 222.48 |
| Expenses | 290.27 | 290.27 |
| Operating Profit | -67.78 | -67.78 |
| OPM % | -30.47% | -30.47% |
| Other Income | 8.69 | 8.69 |
| Interest | 35.63 | 35.63 |
| Depreciation | 44.01 | 44.01 |
| Profit Before Tax | -96.18 | -96.18 |
| Tax % | 0% | 0% |
| Net Profit | -96.18 | -96.18 |
| EPS | -65.63 | -65.63 |
Compounded Sales Growth
10Y
-
5Y
-
3Y
-
TTM
-
Compounded Profit Growth
10Y
-
5Y
-
3Y
-
TTM
-
Stock Price CAGR
10Y
-
5Y
-
3Y
-
1Y
-33.24%
Return on Equity
10Y
-
5Y
-
3Y
-
Last Year
62.96%
Balance Sheet
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 13.1 | 15.1876 |
| Reserves | -152.55 | -167.9497 |
| Borrowings | 256.43 | 163.21 |
| Other Liabilities | 119.76 | 267.46 |
| Total Liabilities | 236.74 | 277.9096 |
| Fixed Assets | 157.22 | 193.302 |
| CWIP | 0 | 0 |
| Investments | 3.63 | 38.69 |
| Other Assets | 75.89 | 45.92 |
| Total Assets | 236.74 | 277.9096 |
Cash Flows
| Mar 2026 | |
|---|---|
| Cash from Operating Activity | 20.5657 |
| Cash from Investing Activity | -63.146 |
| Cash from Financing Activity | 36.6891 |
| Net Cash Flow | -5.8493 |
Ratios
| Mar 2026 | |
|---|---|
| Debtor Days | - |
| Inventory Days | - |
| Days Payable | - |
| Cash Conversion Cycle | - |
| Working Capital Days | 188.18 |
| ROCE % | -59.09% |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 51.43% | 51.43% | 51.43% | 51.43% |
| FIIs % | 0.63% | 0.63% | 0.68% | 0.71% |
| DIIs % | 2.53% | 2.79% | 2.95% | 2.99% |
| Public % | 22.02% | 21.94% | 22.48% | 23.24% |
| No. of Shareholders | 18,724 | 18,295 | 17,932 | 18,043 |
Major Shareholders (>1%)
- Axana Estates LlpPublic Shareholding13.76%
- Harsh C Mariwala With Late Kishore V Mariwala For Valentine Family TrustPromoter and Promoter Group9.37%
- Harsh C Mariwala With Late Kishore V Mariwala For Acquarius Family TrustPromoter and Promoter Group9.37%
- Harsh C Mariwala With Late Kishore V Mariwala For Gemini Family TrustPromoter and Promoter Group9.37%
As of 2026-06-30View all shareholders →